February 07, 2008

Dutton Associates Announces Investment Opinion: Patriot Scientific Rating And Price Target Maintained By Dutton Associates
ROSEVILLE, Calif.--(Business Wire)--
Dutton Associates continues its coverage of Patriot Scientific
(OTCBB: PTSC) maintaining its rating and price target at Speculative
Buy and $.92 respectively. The 14-page report by Dutton senior analyst
Richard W West, CFA is available at www.jmdutton.com as well as from
First Call, Bloomberg, Zacks, Reuters, Knobias, and other leading
financial portals.
Patriot Scientific continues the business course that began in
June 2005. After a change in top management, the Company began to
execute its new strategy to become a dedicated intellectual property
(IP) company by licensing its portfolio of microprocessor patents. In
June 2005 Patriot Scientific ended its litigation surrounding patent
ownership rights and established a partnership with TPL Group. Patriot
Scientific/TPL, through November 30, 2007, granted licenses for the
portfolio of microprocessor patents to over 30 major microprocessor
manufacturers, either directly or through the partnership with TPL.
Since May 2006, these licenses resulted in over $80.0 million in cash
payments to Patriot and since November 30, 2007, has granted licenses
for the portfolio of microprocessor patents to an additional eight
microprocessor manufacturers for an undetermined amount. There are
over 500 companies manufacturing products that make up this market
potential. Patriot Scientific, through the commercialization agreement
with Phoenix Digital, has served notice on approximately 300 companies
that may possibly be infringing on one or more of the patents. Our
update report reviews what we believe are the positive and negative
aspects of Patriot. Based on a number of factors discussed in the
report, we are reiterating our rating and target price.
About Dutton Associates
Dutton Associates is one of the largest independent investment
research firms in the U.S. Its 30 senior analysts are primarily CFAs
and have expertise in many industries. Dutton Associates provides
continuing analyst coverage of over 140 enrolled companies, and its
research, estimates, and ratings are carried in all the major
databases serving institutions and online investors.
The cost of enrollment in our one-year continuing research program
is US $35,000 prepaid for 4 Research Reports, typically published
quarterly, and requisite Research Notes. We received $35,000 from the
Company for 4 Research Reports with coverage commencing on 11/27/2006.
The Firm does not accept any equity compensation. Our principals and
analysts are prohibited from owning or trading in securities of
covered companies. The views expressed in this research report
accurately reflect the analyst's personal views about the subject
securities or issuer. Neither the analyst's compensation nor the
compensation received by us is in any way related to the specific
ratings or views contained in this research report or note. Please
read full disclosures and analyst background at www.jmdutton.com
before investing.
Dutton Associates
John M. Dutton, 916-946-0623
Copyright Business Wire 2008